Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07049900 · ClinicalTrials.gov registry record · NA

Baby ABS (Abdominal Binder Study)

A NA study of Premature and Premature Lungs, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07049900 is a NA study of Premature and Premature Lungs that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants, below the 225-participant average among 4 other Premature trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07049900, a NA study of Premature and Premature Lungs, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier corrected gestational age.

Interventions

  • DEVICE NeoBelly Band

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-22
Est. Completion 2027-02-28
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07049900

The ClinicalTrials.gov registry entry for NCT07049900 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 225-participant average among 4 other Premature trials with a reported enrollment target (82% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Premature appearing as the primary indexed condition, and to 1 intervention - of which NeoBelly Band is the first listed.

NCT07049900 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07049900 about?

NCT07049900 is a clinical study titled "Baby ABS (Abdominal Binder Study)". The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier correct...

What is the current status of trial NCT07049900?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-22. Estimated completion is 2027-02-28.

What conditions does trial NCT07049900 study?

This clinical trial studies the following conditions: Premature, Premature Lungs, Ventilator Lung; Newborn, Rectus Abdominis.

What interventions are being tested in trial NCT07049900?

The interventions under investigation include: NeoBelly Band (DEVICE).

Who is sponsoring clinical trial NCT07049900?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07049900 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.